[{"Assets_0_Q3_USD":4695254000.0,"CommonStockSharesConverted_0_Q3_shares":177902788.0,"CommonStockSharesOutstanding_0_Q3_shares":177902788.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-29166000.0,"NetIncomeLossConverted_1_Q3_USD":-12620000.0,"NetIncomeLossConverted_3_Q3_USD":-73561000.0,"StockholdersEquity_0_Q3_USD":2914945000.0,"EarningsPerShareBasic_1_Q3_USD":-0.07,"EarningsPerShareBasic_3_Q3_USD":-0.42,"RevenuesConverted_1_Q3_USD":391706000.0,"RevenuesConverted_3_Q3_USD":1137998000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181026"}]